AstraZeneca ( NASDAQ:AZN – Get Free Report ) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.09 EPS for the quarter, meeting analysts' consensus estimates of $1.09. The business had revenue of $14.46 billion during the quarter, compared to analyst estimates of $14.08 billion. AstraZeneca had a return on equity of 32.84% and a net margin of 14.68%.AstraZeneca's quarterly revenue was up 16.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.24 EPS. Analysts predict that AstraZeneca PLC will post 4.51 EPS for the current year.